NSE BSE
mankind pharma limited stock

MANKIND PHARMA LIMITED Share Price

- - (%)
- NSE: MANKIND

MANKIND PHARMA LIMITED Share Price Update

As of the latest trading session, MANKIND PHARMA LIMITED share price is currently at 2104.4, which is up by 23.19 from its previous closing. Today, the stock has fluctuated between 2079.30 and 2122.00. Over the past year, MANKIND PHARMA LIMITED has achieved a return of 13.34 %. In the last month alone, the return has been -3.80 %. Read More...

MANKIND PHARMA LIMITED Performance

Day Range

Low2079.30 High2122.00
2129.00

52 Week Range

Low 1683.05 High 2490.00
2129.00

MANKIND PHARMA LIMITED Share Price

15380

543904

MANKIND

img img img img
No Data Available

Open Price

2088.05

Prev. Close

2081.20

Volume (Shares)

548295.00

Total traded value

11673.20

Upper Circuit

2497.40

Lower Circuit

1665.00

Note: The current prices & values are delayed, Login to your account for live updates.

MANKIND PHARMA LIMITED Fundamentals


(Standalone)

Market Cap (Cr) 84299.83
PE Ratio (TTM) 46.78
Book Value / Share 240.21
Beta 0.19
ROE 20.95%
EPS (TTM) 45.51
Dividend Yield 0.00%
Net Profit Qtr (Cr) 454.17

MANKIND PHARMA LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 2152.69
Operating Expense 1691.68
Net Profit 454.17
Net Profit Margin (%) 21.09
Earnings Per Share (EPS) 11.34
EBITDA 631.18
Effective Tax Rate (%) 16.64
Particulars DEC 2023 (Values in Cr)
Revenue 2358.57
Operating Expense 1849.45
Net Profit 487.07
Net Profit Margin (%) 20.65
Earnings Per Share (EPS) 12.16
EBITDA 670.34
Effective Tax Rate (%) 15.49
Particulars SEP 2023 (Values in Cr)
Revenue 2453.35
Operating Expense 1899.50
Net Profit 472.88
Net Profit Margin (%) 19.27
Earnings Per Share (EPS) 11.80
EBITDA 693.31
Effective Tax Rate (%) 22.72
Particulars JUN 2023 (Values in Cr)
Revenue 2300.21
Operating Expense 1831.26
Net Profit 409.28
Net Profit Margin (%) 17.79
Earnings Per Share (EPS) 10.22
EBITDA 596.90
Effective Tax Rate (%) 22.24
Particulars MAR 2023 (Values in Cr)
Revenue 1872.12
Operating Expense 1559.14
Net Profit 280.99
Net Profit Margin (%) 15.00
Earnings Per Share (EPS) 7.01
EBITDA 423.61
Effective Tax Rate (%) 20.94
Particulars MAR 2024 (Values in Cr)
Revenue 9264.81
Operating Expense 7271.88
Net Profit 1823.41
Net Profit Margin (%) 19.68
Earnings Per Share (EPS) 45.52
EBITDA 2591.75
Effective Tax Rate (%) 19.30
Particulars MAR 2023 (Values in Cr)
Revenue 8127.15
Operating Expense 6727.10
Net Profit 1248.26
Net Profit Margin (%) 15.35
Earnings Per Share (EPS) 31.16
EBITDA 1860.16
Effective Tax Rate (%) 20.12
Particulars MAR 2022 (Values in Cr)
Revenue 7486.22
Operating Expense 5818.59
Net Profit 1389.42
Net Profit Margin (%) 18.55
Earnings Per Share (EPS) 34.68
EBITDA 2041.88
Effective Tax Rate (%) 25.75
Particulars MAR 2021 (Values in Cr)
Revenue 5523.18
Operating Expense 4237.46
Net Profit 1084.37
Net Profit Margin (%) 19.63
Earnings Per Share (EPS) 27.07
EBITDA 1526.38
Effective Tax Rate (%) 24.70
Particulars MAR 2024 (Values in Cr)
Book Value / Share 233.73
ROE % 23.12
ROCE % 27.91
Total Debt to Total Equity 0.02
EBITDA Margin 27.41
Particulars MAR 2023 (Values in Cr)
Book Value / Share 185.61
ROE % 19.27
ROCE % 23.11
Total Debt to Total Equity 0.08
EBITDA Margin 23.35
Particulars MAR 2022 (Values in Cr)
Book Value / Share 153.65
ROE % 26.72
ROCE % 33.43
Total Debt to Total Equity 0.10
EBITDA Margin 28.29
Particulars MAR 2021 (Values in Cr)
Book Value / Share 117.88
ROE % 31.51
ROCE % 39.19
Total Debt to Total Equity 0.05
EBITDA Margin 29.48
Particulars MAR 2020 (Values in Cr)
Book Value / Share 87.00
ROE % 30.30
ROCE % 39.51
Total Debt to Total Equity 0.04
EBITDA Margin 26.60
Particulars MAR 2024 (Values in Cr)
Book Value / Share 240.24
ROE % 20.95
ROCE % 25.77
Total Debt to Total Equity 0.00
EBITDA Margin 27.98
Particulars MAR 2023 (Values in Cr)
Book Value / Share 194.31
ROE % 17.43
ROCE % 20.91
Total Debt to Total Equity 0.05
EBITDA Margin 22.89
Particulars MAR 2022 (Values in Cr)
Book Value / Share 163.27
ROE % 24.65
ROCE % 31.42
Total Debt to Total Equity 0.07
EBITDA Margin 27.28
Particulars MAR 2021 (Values in Cr)
Book Value / Share 118.18
ROE % 25.86
ROCE % 33.63
Total Debt to Total Equity 0.01
EBITDA Margin 27.64
Particulars MAR 2020 (Values in Cr)
Book Value / Share 91.15
ROE % 28.53
ROCE % 36.39
Total Debt to Total Equity 0.03
EBITDA Margin 27.90
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1197.97
Total Assets 11963.25
Total Liabilities 11963.25
Total Equity 9575.78
Share Outstanding 400588440
Price to Book Ratio 9.56
Return on Assets (%) 15.98
Return on Capital (%) 19.58
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 453.19
Total Assets 9715.44
Total Liabilities 9715.44
Total Equity 7623.29
Share Outstanding 400588440
Price to Book Ratio 0.00
Return on Assets (%) 13.19
Return on Capital (%) 16.46
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 405.94
Total Assets 9147.73
Total Liabilities 9147.73
Total Equity 6316.31
Share Outstanding 400588440
Price to Book Ratio 0.00
Return on Assets (%) 15.67
Return on Capital (%) 19.95
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 700.74
Total Assets 6372.63
Total Liabilities 6372.63
Total Equity 4862.88
Share Outstanding 400588440
Price to Book Ratio 0.00
Return on Assets (%) 19.85
Return on Capital (%) 24.82
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 419.87
Total Assets 5073.28
Total Liabilities 5073.28
Total Equity 3671.57
Share Outstanding 400588440
Price to Book Ratio 0.00
Return on Assets (%) 20.31
Return on Capital (%) 27.13
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 761.01
Total Assets 11417.71
Total Liabilities 11417.71
Total Equity 9623.80
Share Outstanding 400588440
Price to Book Ratio 9.56
Return on Assets (%) 15.97
Return on Capital (%) 18.95
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 155.15
Total Assets 9371.12
Total Liabilities 9371.12
Total Equity 7783.91
Share Outstanding 400588440
Price to Book Ratio 0.00
Return on Assets (%) 13.32
Return on Capital (%) 16.04
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 138.84
Total Assets 8938.70
Total Liabilities 8938.70
Total Equity 6540.45
Share Outstanding 400588440
Price to Book Ratio 0.00
Return on Assets (%) 15.54
Return on Capital (%) 19.23
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 476.94
Total Assets 5880.33
Total Liabilities 5880.33
Total Equity 4734.27
Share Outstanding 400588440
Price to Book Ratio 0.00
Return on Assets (%) 18.44
Return on Capital (%) 22.45
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 197.94
Total Assets 4531.10
Total Liabilities 4531.10
Total Equity 3651.45
Share Outstanding 400588440
Price to Book Ratio 0.00
Return on Assets (%) 21.14
Return on Capital (%) 26.24
Particulars MAR 2024 (Values in Cr)
Net Income 2399.35
Cash from Operations 2631.97
Cash from Investing -2081.69
Cash from Financing 5.26
Net change in Cash 76.02
Free Cash Flow 2947.31
Particulars MAR 2023 (Values in Cr)
Net Income 1671.23
Cash from Operations 2136.39
Cash from Investing -1054.12
Cash from Financing -739.72
Net change in Cash 19.44
Free Cash Flow 2925.41
Particulars MAR 2022 (Values in Cr)
Net Income 1974.60
Cash from Operations 1419.28
Cash from Investing -1369.14
Cash from Financing 604.62
Net change in Cash 155.25
Free Cash Flow 1884.15
Particulars MAR 2021 (Values in Cr)
Net Income 1691.61
Cash from Operations 1591.31
Cash from Investing -1222.21
Cash from Financing -7.81
Net change in Cash -92.77
Free Cash Flow 1896.73
Particulars MAR 2020 (Values in Cr)
Net Income 1437.73
Cash from Operations 1400.61
Cash from Investing -439.15
Cash from Financing -530.73
Net change in Cash 99.81
Free Cash Flow 1603.42
Particulars MAR 2024 (Values in Cr)
Net Income 2259.56
Cash from Operations 2380.52
Cash from Investing -1919.11
Cash from Financing -8.68
Net change in Cash 55.17
Free Cash Flow 2569.43
Particulars MAR 2023 (Values in Cr)
Net Income 1562.83
Cash from Operations 2084.05
Cash from Investing -1040.61
Cash from Financing -710.41
Net change in Cash 47.96
Free Cash Flow 2632.41
Particulars MAR 2022 (Values in Cr)
Net Income 1871.43
Cash from Operations 1281.66
Cash from Investing -1360.26
Cash from Financing 578.62
Net change in Cash 39.80
Free Cash Flow 1583.01
Particulars MAR 2021 (Values in Cr)
Net Income 1440.20
Cash from Operations 1380.75
Cash from Investing -1127.15
Cash from Financing 88.86
Net change in Cash -54.91
Free Cash Flow 1570.94
Particulars MAR 2020 (Values in Cr)
Net Income 1264.92
Cash from Operations 1233.73
Cash from Investing -395.67
Cash from Financing -558.91
Net change in Cash 5.01
Free Cash Flow 1399.22
Company Name Price P/E P/B Market Cap 52 Week Low/High
Company Name Price P/E P/B Market Cap 52 Week Low/High
MANKIND PHARMA LIMITED 2129.00 46.78 8.86 85295.22 1680.50 / 2488.65
AMRUTAJAN HEALTH LTD 738.70 47.47 7.40 2135.63 556.05 / 826.00
ASTRAZENECA PHARMA IND LT 6349.65 106.48 22.29 15874.13 3730.00 / 7550.00
BLISS GVS PHARMA LTD 110.15 15.17 1.16 1155.28 77.65 / 148.95
ABBOTT INDIA LIMITED 27407.65 48.49 15.74 58241.26 21907.45 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 2131.10
  • 26 Days 2145.30
  • 10 Days 2135.60
  • 50 Days 2149.50
  • 12 Days 2130.80
  • 100 Days 2180.20
  • 20 Days 2141.60
  • 200 Days 1816.00
2132.60
PIVOT
First Resistance 2149.05
Second Resistance 2159.25
Third Resistance 2175.70
First Support 2122.40
Second Support 2105.95
Third Support 2095.75
RSI 49.98
MACD -14.52
Commodity Channel Index (CCI) -41.75
ADX 12.13
Williams % R -53.72

Over 1 Month

down

-3.80

Over 3 Months

down

-8.91

Over 6 Months

down

-1.45

Over 1 Year

down

13.34

Over 3 Years

down

0.00

Over 5 Years

down

0.00

MANKIND PHARMA LIMITED Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

MANKIND PHARMA LIMITED Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
6.18
Promoter Holdings
74.87
FII
11.57
DII
7.36
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Ramesh Juneja Family Trust (held In The Name Of Ramesh Juneja, Managing Trustee) Shareholding of Promoter and Promoter Group 8.3352652E7 20.81
Rajeev Juneja Family Trust (held In The Name Of Rajeev Juneja, Managing Trustee) Shareholding of Promoter and Promoter Group 7.993052E7 19.95
Prem Sheetal Family Trust (held In The Name Of Arora Family Private Limited, Trustee) Shareholding of Promoter and Promoter Group 6.1755635E7 15.41
Sheetal Arora Shareholding of Promoter and Promoter Group 1.9277647E7 4.81
Puja Juneja Shareholding of Promoter and Promoter Group 1.1533906E7 2.88
Poonam Juneja Shareholding of Promoter and Promoter Group 1.0557626E7 2.64
Arjun Juneja Shareholding of Promoter and Promoter Group 8154463.0 2.04
Ramesh Juneja Shareholding of Promoter and Promoter Group 6855990.0 1.71
Rajeev Juneja Shareholding of Promoter and Promoter Group 6500021.0 1.62
Hema Cipef (i) Limited Public Shareholding 6497968.0 1.62
Sbi Large & Midcap Fund Public Shareholding 6007684.0 1.5
Axis Mutual Fund Trustee Limited A/c Axis Mutual F Public Shareholding 5121093.0 1.28
Icici Prudential Mutual Fund - Icici Prudential Ni Public Shareholding 4018594.0 1.0
Chanakya Juneja Shareholding of Promoter and Promoter Group 3896788.0 0.97
Eklavya Juneja Shareholding of Promoter and Promoter Group 3896788.0 0.97
Mishka Arora Shareholding of Promoter and Promoter Group 2955692.0 0.74
Ria Chopra Juneja Shareholding of Promoter and Promoter Group 1292884.0 0.32
Greesh Kumar Juneja Shareholding of Promoter and Promoter Group 0.0 0.0
Rajeev Juneja And Sons Huf (rajeev Juneja - Karta) Shareholding of Promoter and Promoter Group 0.0 0.0
R C Juneja And Sons Huf (ramesh Juneja- Karta) Shareholding of Promoter and Promoter Group 0.0 0.0
Kusum Lata Dua Shareholding of Promoter and Promoter Group 0.0 0.0
Mohit Vij Shareholding of Promoter and Promoter Group 0.0 0.0
Rekha Vij Shareholding of Promoter and Promoter Group 0.0 0.0
Yogi Raj Vij Shareholding of Promoter and Promoter Group 0.0 0.0
Viralika Arora Shareholding of Promoter and Promoter Group 0.0 0.0
Esha Arora Tewari Shareholding of Promoter and Promoter Group 0.0 0.0
Nidhi Arora Shareholding of Promoter and Promoter Group 0.0 0.0
Prabha Arora Shareholding of Promoter and Promoter Group 0.0 0.0
Prem Kumar Arora Shareholding of Promoter and Promoter Group 0.0 0.0
Gautam Madan Shareholding of Promoter and Promoter Group 0.0 0.0
Sanjay Madan Shareholding of Promoter and Promoter Group 0.0 0.0
Asha Madan Shareholding of Promoter and Promoter Group 0.0 0.0
Ashok Kumar Shareholding of Promoter and Promoter Group 0.0 0.0
Geeta Agarwal Shareholding of Promoter and Promoter Group 0.0 0.0
Rajeev Mohan Agarwal Shareholding of Promoter and Promoter Group 0.0 0.0
Pushpa Rani Aggarwal Shareholding of Promoter and Promoter Group 0.0 0.0
Ayushi Juneja Sikri Shareholding of Promoter and Promoter Group 0.0 0.0
Wellspur Foundation Shareholding of Promoter and Promoter Group 0.0 0.0
Acche Karam Hospitality Llp Shareholding of Promoter and Promoter Group 0.0 0.0
A To Z Packers Shareholding of Promoter and Promoter Group 0.0 0.0
Anm Holdings Pte Ltd Shareholding of Promoter and Promoter Group 0.0 0.0
Casablanca Pharma Pte Ltd Shareholding of Promoter and Promoter Group 0.0 0.0
Salute Bestochem Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Petal Pharma Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Biovein Innovative Solutions Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Bigbrother Nutra Care Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Besto Herbs Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Quality Bestochem Formulations Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
G.a. Davai India Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Bestochem Formulations (india) Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Virmish Enterprises Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Teen Murti Products Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Star Infra Developers Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Saburi Sai Ram Buildtech Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Saburi Projects Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Saburi Enterprises Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Saburi Consultants Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Rpj Trustee Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Rotokind Technologies Shareholding of Promoter and Promoter Group 0.0 0.0
Rcj Advisors Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Rashmi Exports Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Rashi Apparels Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Printman Shareholding of Promoter and Promoter Group 0.0 0.0
Pp & A Combines Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Pathkind Diagnostics Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Paonta Process Equipments Shareholding of Promoter and Promoter Group 0.0 0.0
Om Sai Pharma Pack Shareholding of Promoter and Promoter Group 0.0 0.0
Nextwave India Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Mankind Drugs Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Mankind Biotech Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Appian Multiventures Private Limited (formerly Known As Mankind Biosys Private Limited) Shareholding of Promoter and Promoter Group 0.0 0.0
Luxor Metaltec (india) Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
J & A Partners Shareholding of Promoter and Promoter Group 0.0 0.0
Intercity Corporate Towers Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Gyan Infrastructure Company Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Casablanca Securities Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Casablanca Pharma Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Casablanca Lifesciences Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Beckon Realestate Developers Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Ayushi And Poonam Estates Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Arora Family Pvt Ltd Shareholding of Promoter and Promoter Group 0.0 0.0
Appian Projects Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Appian Buildwell Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Appian Buildrise Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Appian Buildheights Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Appian Associates Infrastructure Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Anm Properties Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Alankrit Handicrafts Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Ajs Properties Shareholding of Promoter and Promoter Group 0.0 0.0
Ace Overseas Ventures Shareholding of Promoter and Promoter Group 0.0 0.0

MANKIND PHARMA LIMITED

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About MANKIND PHARMA LIMITED

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by MANKIND PHARMA LIMITED

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Mankind Pharma Ltd?

Answer Field

The share price of Mankind Pharma Ltd for NSE is ₹ 2104.4 and for BSE is ₹ 2110.3.

What is the Market Cap of Mankind Pharma Ltd?

Answer Field

The market cap of Mankind Pharma Ltd for NSE is ₹ 8,42,99.83 Cr. and for BSE is ₹ 8,45,36.19 Cr. as of now.

What is the 52 Week High and Low of Mankind Pharma Ltd?

Answer Field

The 52 Week High and Low of Mankind Pharma Ltd for NSE is ₹ 2490.00 and ₹ 1683.05 and for BSE is ₹ 2488.65 and ₹ 1680.50.

How to Buy Mankind Pharma Ltd share?

Answer Field

You can trade in Mankind Pharma Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Mankind Pharma Ltd?

Answer Field

The 1 year returns on the stock has been 13.34%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader